LAVA Therapeutics
LVTX
LVTX
20 hedge funds and large institutions have $12.5M invested in LAVA Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+6
Holders Change %
+42.86%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
1
Reduced
2
Closed
5
Calls
$102K
Puts
$203K
Net Calls
-$101K
Net Calls Change
-$135K
Top Buyers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.22M |
| 2 |
Walleye Capital
New York
|
+$515K |
| 3 |
Two Sigma Investments
New York
|
+$273K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$60.9K |
| 5 |
Two Sigma Advisers
New York
|
+$55.6K |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$2.97M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.33M |
| 3 |
Morgan Stanley
New York
|
-$131K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$34.1K |
| 5 |
Millennium Management
New York
|
-$26.8K |
